Search results
14 lip 2021 · Glioblastoma is the most common primary brain cancer in adults. 1 Despite surgical resection, chemotherapy, and radiotherapy, median survival after diagnosis is only 14-16 months. …
- Related Content
### What you need to know Glioblastoma is the most common...
- Article Tab
### What you need to know Glioblastoma is the most common...
- Vol 374, Issue 8300
Covid-19: Free rapid testing may end once most adults are...
- CrossRef
Delayed diagnosis of brain tumors in children has been...
- BMJ Article Related Rapid Responses
{"markup":"\u003C?xml version=\u00221.0\u0022...
- Download
Chętnie wyświetlilibyśmy opis, ale witryna, którą oglądasz,...
- Related Content
Contrary to the results of the univariate analysis, multivariate analysis revealed that only grade and surgery were independent prognostic factors for GBM patients (HR = 13.812, 95% CI [3.333–57.242]; HR = 0.566, 95% CI [0.349–0.917]), but not age, radiotherapy, and chemotherapy.
The average glioblastoma survival time is 12-18 months – only 25% of patients survive more than one year, and only 5% of patients survive more than five years.
22 cze 2017 · Glioblastoma (GBM) is a rare tumor and one of the most challenging malignancies to treat in all of oncology. Although advances have been made in the treatment of GBM, encouraging outcomes typically are not observed; patients diagnosed with these tumors generally have a dismal prognosis and poor quality of life as the disease progresses.
24 kwi 2020 · The overall age-adjusted incidence of glioblastoma in the United States is 3.22/100 000 persons, and increases with advanced age at diagnosis and male sex (Fig. 1A; Central Brain Tumor Registry of the United States, 2012–2016). 1 Incidence also varies worldwide. 5 Recent data show no trend toward increased incidence in the US or Canada, 6 ...
1 cze 2020 · Overall, the prognosis for patients with this disease is poor, with a median survival of <2 years. There is a slight predominance in males, and incidence increases with age. The standard approach to therapy in the newly diagnosed setting includes surgery followed by concurrent radiotherapy with temozolomide and further adjuvant temozolomide.
15 lip 2020 · Meta-analyses of real-world data suggested a doubling of 2- and 3-year survival in glioblastoma patients since 2005. However, 5-year survival remains poor with no apparent improvement.
